PTGX
#1010
Protagonist Therapeutics, Inc. - Common Stock
131.3 6 USD
+0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.13%
Variación mensual
+19.42%
Variación en los últimos 6 meses
+55.27%
Cambio anual
+74.84%
Cierres anteriores
129.8 9
Open
130.5 9
Mínimo
130.3 2
High
131.9 5
Volumen
274
Financials
- Market Capitalization 8.45 B
- Employee 131
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-42.6
Relación precio/flujo de caja
120.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 990 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 98.95 USD | +5.57% | +5.01% | +21.31% | +313.84% | 8.59 B USD | ||
| 1006 |  TGTX TG Therapeutics, Inc. - Common Stock | 54.92 USD | -0.16% | -5.41% | +12.08% | +40.86% | 8.41 B USD | ||
| 1016 |  IBRX ImmunityBio, Inc. - Common Stock | 7.88 USD | +1.16% | -10.05% | +8.69% | +169.86% | 8.25 B USD | ||
| 1018 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.96 USD | +0.10% | +0.28% | +49.41% | +149.97% | 8.29 B USD |